Key facts
- This page summarizes David P. Hochman's Form 4 filing for Orchestra BioMed Holdings, Inc. (OBIO).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 04 Apr 2025, 21:44.
David P. Hochman - 04 Apr 2025 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)
- Reporting relationship
- Chief Executive Officer and Chairperson, Director
- Issuer ticker
- OBIO
- Reported as of
- 04 Apr 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 04 Apr 2025, 21:44:39 UTC
- Prior SEC filing
- 07 Mar 2025
- Next SEC filing
- 13 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Andrew Taylor, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
David P. Hochman filed Form 4 for Orchestra BioMed Holdings, Inc. (OBIO) on 04 Apr 2025.
Change
- Previous filing in this sequence was filed on 07 Mar 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OBIO
transaction
Common Stock, par value $0.0001 per share ("Common Stock")
Award
- Transaction value
- $0
- Shares
- +98,333
- Change %
- +20%
- Price
- $0.000000
- Shares after
- 579,498
- Date
- 04 Apr 2025
- Ownership
- Direct
- Footnotes
- F1
OBIO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 335,002
- Date
- 04 Apr 2025
- Ownership
- By the DPH 2008 Trust
OBIO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,000
- Date
- 04 Apr 2025
- Ownership
- By the Solomon Ascher Hochman 2019 Trust
OBIO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,000
- Date
- 04 Apr 2025
- Ownership
- By the Hannah Hochman 2019 Trust
OBIO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,000
- Date
- 04 Apr 2025
- Ownership
- By the Judah Herman Hochman 2019 Trust
OBIO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,140
- Date
- 04 Apr 2025
- Ownership
- By the NSH 2008 Family Trust
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
OBIO
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +147,500
- Change %
- Price
- $0.000000
- Shares after
- 147,500
- Date
- 04 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 147,500
- Exercise price
- $2.76
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest over a three-year period as follows: (i) 33.33% of the shares will vest 24 months after April 4, 2025 (the "Issue Date"), (ii) 33.33% of the shares will vest 30 months after the Issue Date, and (iii) 33.34% of the shares will vest 36 months after the Issue Date, subject to the Reporting Person's continuous service through such dates.
Footnote F2
The stock options will vest as follows: (i) 36,875 of the stock options will vest on April 4, 2026 (the "Vesting Commencement Date") and (ii) the remaining 110,625 stock options will vest in equal installments every three months on the same day of the month as the Vesting Commencement Date, starting on July 4, 2026, subject to the Reporting Person's continuous service through such dates.
SEC remarks
Chief Executive Officer and Chairperson